This IMTS planning outline helps a manufacturer organize source materials before drafting. It is an original working aid, not an official European Commission template, a completed CER, or a substitute for clinical judgment.

What Annex XIV requires, and what an outline adds

Annex XIV Part A addresses clinical evaluation, including its planning, evidence assessment and documentation. A report outline should support those activities while making device-specific conclusions traceable. The regulation does not supply a universal, pre-approved manufacturer report layout.

MDCG 2020-13 is a notified body clinical evaluation assessment report template. Do not relabel it as an official manufacturer CER template. A manufacturer may organize its report differently, provided the applicable evaluation requirements are addressed and the supporting records can be followed.

A working CER structure

Scope and control: report version, authors and review responsibilities; evaluated models, intended purpose, claims, users and population; linked source-document versions. State the evidence cut-off and any exclusions from the device family.

Clinical context and methods: condition and treatment pathway, state-of-the-art questions, relevant benchmarks, evidence sources, search and selection methods, appraisal approach and planned synthesis. Reference the approved CEP and explain changes.

Evidence and interpretation: relevant device data, any separately justified equivalence position, literature appraisal, safety and performance analysis, clinical benefits, benefit-risk reasoning and unresolved uncertainties. Favorable and unfavorable findings need an explicit place in the analysis.

Lifecycle and handover: implications for PMS and PMCF, supported conclusions, remaining actions, next review triggers, references and appendices. Identify the owner of any unresolved clinical or regulatory decision.

Use the downloadable outline as an input checklist

The downloadable HTML worksheet opens in a browser and can be printed or saved as PDF. It contains section prompts and blank input fields for your own working copy. No email address is required, and entries remain in that open browser document; IMTS does not receive them.

Begin by listing source records against each heading. A blank evidence cell is useful information: it shows that drafting may depend on a missing study, unconfirmed claim or unavailable reference. Complete the clinical argument before polishing the language. A populated template still needs appropriate authoring, review and manufacturer approval.

An illustrative traceability check

Suppose the intended benefit is sustained symptom improvement but the available study measures only immediate device performance. Enter the intended benefit, study endpoint, follow-up and limitation in separate fields. The outline should expose the unsupported connection rather than encourage a stronger claim.

This is an illustrative appraisal example, not a client case or a proposed acceptance criterion. For evidence retrieval, use the CER literature search protocol guide. For the planning document itself, see CEP writing support.

Turn the outline into a scoped project

Before requesting a quotation, identify the device family, existing CEP/CER, evidence period, literature-review records and known reviewer questions. Decide whether you need a new evaluation, a routine update or a finding-led correction. The same outline can organize inputs, but those projects require different work.

IMTS can help turn the device-specific evidence and methods into a report with transparent conclusions. The agreed scope should identify the deliverables, source responsibilities, comment rounds and handover records; a template download does not include a clinical evaluation or independent reviewer sign-off.

Common questions

Is this an official EU MDR CER template?

No. It is an original IMTS planning outline. It supports document organization and input collection; it is not issued or endorsed by a regulator or notified body.

Can I use the outline for any device?

Adapt it to the device and applicable requirements. The evidence, methods and review responsibilities must be determined for the specific intended purpose, claims and risks.

Is the downloadable outline a completed CER?

No. It contains prompts and working fields, not an evaluated device, clinical conclusions or an approval statement.

Download the CER planning outline

A free, editable browser worksheet with input prompts and a claim-to-evidence table. No email required.

Download the HTML outline

Open the outline in a browser. Use Print to save a PDF.

Primary regulatory sources

Check the applicable consolidated legislation and current guidance for the device. Guidance supports interpretation; it does not replace the MDR or a device-specific assessment.

Connected services and working guides